GAMC
ABBV icon

Garner Asset Management Corp’s AbbVie ABBV Stock Holding History

Garner Asset Management Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Sell
1,384
-62
-4% -$13.3K 0.11% 138
2026
Q1 		$314K Sell
1,446
-39
-3% -$8.65K 0.12% 134
2025
Q4 		$339K Sell
1,485
-84
-5% -$19.1K 0.13% 132
2025
Q3 		$363K Sell
1,569
-160
-9% -$32.6K 0.15% 128
2025
Q2 		$321K Sell
1,729
-140
-7% -$26K 0.15% 128
2025
Q1 		$392K Sell
1,869
-81
-4% -$15.7K 0.17% 125
2024
Q4 		$347K Sell
1,950
-108
-5% -$19.9K 0.16% 122
2024
Q3 		$407K Sell
2,058
-126
-6% -$23.5K 0.18% 119
2024
Q2 		$375K Sell
2,184
-27
-1% -$4.47K 0.18% 121
2024
Q1 		$403K Buy
2,211
+65
+3% +$11.2K 0.2% 117
2023
Q4 		$375K Sell
2,146
-208
-9% -$30.3K 0.18% 114
2023
Q3 		$351K Sell
2,354
-7
-0.3% -$1.03K 0.2% 114
2023
Q2 		$318K Sell
2,361
-1,007
-30% -$148K 0.18% 126
2023
Q1 		$537K Sell
3,368
-30
-0.9% -$4.59K 0.25% 112
2022
Q4 		$549K Buy
3,398
+3
+0.1% +$460 0.26% 107
2022
Q3 		$456K Sell
3,395
-713
-17% -$102K 0.24% 114
2022
Q2 		$629K Buy
4,108
+673
+20% +$103K 0.27% 108
2022
Q1 		$557K Buy
3,435
+3
+0.1% +$436 0.22% 119
2021
Q4 		$465K Buy
3,432
+4
+0.1% +$473 0.19% 130
2021
Q3 		$370K Buy
3,428
+3
+0.1% +$343 0.17% 144
2021
Q2 		$386K Buy
+3,425
New +$386K 0.18% 138
2021
Q1 		– Sell
-1,999
Closed -$214K – 162
2020
Q4 		$214K Buy
+1,999
New +$192K 0.12% 151
2020
Q3 		– Sell
-2,068
Closed -$203K – 154
2020
Q2 		$203K Buy
+2,068
New +$182K 0.15% 141

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garner Asset Management Corp's ABBV Position: Q2 2026 in Review

Garner Asset Management Corp reduced its AbbVie (ABBV) stake by 4.3% in Q2 2026, selling an estimated $13.3K and leaving 1,384 shares worth $348K. The position accounts for 0.11% of the portfolio, ranked #138.

Garner Asset Management Corp first reported a position in ABBV in Q2 2020 and has held it in 23 quarters since. The position peaked at $629K in Q2 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Garner Asset Management Corp held 1,384 shares of AbbVie worth $348K as of Q2 2026.
  • Garner Asset Management Corp sold 62 AbbVie shares in Q2 2026, an estimated $13.3K.
  • AbbVie made up 0.11% of Garner Asset Management Corp's portfolio in Q2 2026, its #138 holding.
  • Garner Asset Management Corp first reported a position in AbbVie in Q2 2020 and has held it in 23 quarters since.
  • Garner Asset Management Corp's AbbVie position peaked at $629K in Q2 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garner Asset Management Corp's 13F filing for Q2 2026, filed 7 Aug 2026.